|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
other routine vaccines (with caution)
|
|
gptkbp:age
|
2 to 55 years
|
|
gptkbp:approvalYear
|
2005
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
gptkb:J07AH08
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:broadcastOn
|
2-dose series for adolescents
|
|
gptkbp:CDCRecommended
|
yes
|
|
gptkbp:containsAdjuvant
|
no
|
|
gptkbp:containsAntigen
|
meningococcal polysaccharide conjugated to diphtheria toxoid
|
|
gptkbp:containsLatex
|
no
|
|
gptkbp:containsPreservative
|
no
|
|
gptkbp:containsThimerosal
|
no
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
hypersensitivity to any component
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Menactra
|
|
gptkbp:manufacturer
|
gptkb:Sanofi_Pasteur
|
|
gptkbp:marketedIn
|
gptkb:Canada
gptkb:United_States
various countries worldwide
|
|
gptkbp:notRecommendedFor
|
children under 2 years
adults over 55 years
|
|
gptkbp:pregnancyCategory
|
Category C (US)
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:protectedBy
|
gptkb:Neisseria_meningitidis_serogroup_A
gptkb:Neisseria_meningitidis_serogroup_C
gptkb:Neisseria_meningitidis_serogroup_W-135
gptkb:Neisseria_meningitidis_serogroup_Y
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
injection site pain
redness
swelling
|
|
gptkbp:storage
|
2°C to 8°C
|
|
gptkbp:usedFor
|
prevention of meningococcal disease
|
|
gptkbp:vaccineType
|
vaccine
|
|
gptkbp:WHOPrequalified
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Sanofi
|
|
gptkbp:bfsLayer
|
5
|